Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001738995-20-000001
Filing Date
2020-05-12
Accepted
2020-05-12 13:15:51
Documents
1
Effectiveness Date
2020-05-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7091
  Complete submission text file 0001738995-20-000001.txt   8145
Mailing Address 1928 OLD MIDDLEFIELD WAY, SUITE B MOUNTAIN VIEW CA 94043
Business Address 1928 OLD MIDDLEFIELD WAY, SUITE B MOUNTAIN VIEW CA 94043 650-248-7914
Tulavi Therapeutics, Inc. (Filer) CIK: 0001738995 (see all company filings)

EIN.: 824929716 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-366728 | Film No.: 20868364